Evidence map›Paper›PMID 30567283›Full record

ArticleBMJ case reports2018

Martina Ferranti, Giulia Tadiotto Cicogna, Andrea Sattin, Mauro Alaibac

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Flood-derived sludge as a reservoir of viable opportunistic pathogens after the October 2024 DANA in Valencia (Spain).International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Martina FerrantiUnit of Dermatology, University of Padua, Padua, Italy.
Giulia Tadiotto CicognaUnit of Dermatology, University of Padua, Padua, Italy.
Andrea SattinUnit of Infectious Disease, University of Padua, Padua, Italy.
Mauro AlaibacUnit of Dermatology, University of Padua, Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pemphigus vulgaris is an autoimmune bullous disease that involves the skin and mucous membranes. Current therapies aim to decrease antibody production by means of the use of systemic corticosteroids, immunosuppressive agents and, recently, rituximab, an anti-CD20 monoclonal antibody. However, the chronic immune suppression could entail complications, like infections and secondary malignancies. We describe a case of a patient with pemphigus who developed a sepsis due to

Indexed as

Citrobacter freundiiImmunocompromised HostAgedAnti-Bacterial AgentsDiagnosis, DifferentialEnterobacteriaceae InfectionsHumansImmunologic FactorsMalePemphigusRituximabAnti-Bacterial AgentsImmunologic FactorsRituximabdermatologyinfections

Identifiers

PMID30567283
PMCPMC6301621
OpenAlexW2904499598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.